Keyphrases
Adverse Effects
40%
Anti-inflammatory Drugs
20%
Biomarkers Therapeutic Target
20%
Carcinoma
60%
Cardiovascular Events
20%
Chemoprevention
20%
Chronic Inflammation
20%
Dihydroxyeicosatrienoic Acid
20%
Dysplasia
20%
Epoxyeicosatrienoic Acids
100%
Highly Selective
20%
Human Carcinoma
20%
Human Tissue
20%
Inflammation
100%
Mouse Colitis
20%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
40%
Novel Biomarkers
20%
Oncogenesis
100%
Preventive Effect
20%
Putative Drug Targets
100%
Soluble Epoxide Hydrolase
100%
Soluble Epoxide Hydrolase Inhibitor
20%
Ulcer
40%
Ulcerative Colitis
60%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
33%
Biological Marker
16%
Carcinogenesis
100%
Carcinoma
66%
Chronic Inflammation
16%
Colitis
16%
Dysplasia
16%
Epoxide Hydrolase
100%
Epoxyicosatrienoic Acid
100%
Hydrolase Inhibitor
16%
Inflammation
100%
Non-Steroidal Anti-Inflammatory Drug
33%
Side Effect
33%
Ulcer
33%
Ulcerative Colitis
33%